StockData
QuidelOrtho Corp logo

QuidelOrtho Corp (QDEL) stock

QDELNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends January 1
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3063% below fair value
$9.57−0.30 (-3.04%)

Close on Nov 18, 2026Market cap $656.27MP/E –Yield –

QuidelOrtho revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

QuidelOrtho's revenue for the twelve months ending Sep 27, 2026 was $2.59B, down 4.5% year over year. For fiscal 2025 it was $2.73B, down 1.9% from the year before. The highest annual figure on record is $3.27B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 28, 2025$2.73B-1.9%
FY2024Dec 29, 2024$2.78B-7.2%
FY2023Dec 31, 2023$3.00B-8.2%
FY2022Jan 1, 2023$3.27B+92.3%
FY2021Jan 2, 2022$1.70B+2.2%
FY2020Jan 3, 2021$1.66B–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$618.90M-11.6%
Q2 FY2026Jun 28, 2026$630.90M+2.8%
Q1 FY2026Mar 29, 2026$619.80M-10.5%
Q4 FY2025Dec 28, 2025$723.60M+2.2%
Q3 FY2025Sep 28, 2025$699.90M-3.7%
Q2 FY2025Jun 29, 2025$613.90M-3.6%
Q1 FY2025Mar 30, 2025$692.80M-2.6%
Q4 FY2024Dec 29, 2024$707.80M-4.7%
Q3 FY2024Sep 29, 2024$727.10M-2.3%
Q2 FY2024Jun 30, 2024$637.00M-4.2%
Q1 FY2024Mar 31, 2024$711.00M-16.0%
Q4 FY2023Dec 31, 2023$742.60M-14.3%
Q3 FY2023Oct 1, 2023$744.00M-5.1%
Q2 FY2023Jul 2, 2023$665.10M+8.4%
Q1 FY2023Apr 2, 2023$846.10M-15.6%
Q4 FY2022Jan 1, 2023$866.50M+36.0%
Q3 FY2022Oct 2, 2022$783.80M+53.7%
Q2 FY2022Jul 3, 2022$613.40M+247.3%
Q1 FY2022Apr 3, 2022$1.00B–
Q4 FY2021Jan 2, 2022$636.90M–
Q3 FY2021Oct 3, 2021$509.80M–
Q2 FY2021Jul 4, 2021$176.60M–

More QuidelOrtho figures

See a number that looks wrong?